| Ytd | -39.22% | |
| 1y | -19.21% |
| Open | 2.75 | Prev Close | 2.72 | Low | 2.66 | High | 2.77 | Mkt Cap | 121.74M |
| Vol | 48.50K | Avg Vol | 202.27K | EPS | -0.85 | P/E | -3.19 | Forward P/E | -2.45 |
| Beta | 0.60 | Short Ratio | 8.90 | Inst. Own | 15.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 2.92 | 200-d Avg | 3.45 | 1yr Est | 18.40 |
GNLX News
Genelux (NASDAQ: GNLX - Get Free Report) is expected to post its Q2 2026 results before the market o
- Findings provide mechanistic support for previously reported clinical outcomes of clinical reversa
-- Topline data from randomized Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi
-- Topline data from Phase 3 OnPrime/GOG-3076 ovarian cancer registrational trial of Olvi-Vec expect
WESTLAKE VILLAGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq:
WESTLAKE VILLAGE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq:
WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a l
-- Lung cancer programs progressing with interim data updates expected in Q4 2025 -- -- Topline data
WESTLAKE VILLAGE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
Genelux Corporation (GNLX) might move higher on growing optimism about its earnings prospects, which
WESTLAKE VILLAGE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a lat
– Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway f
Genelux Corporation (GNLX) is technically in oversold territory now, so the heavy selling pressure m
WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq
WESTLAKE VILLAGE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a la
Topline results from phase 3 OnPrime/GOG-3076 study using Olvi-Vec for the treatment of patients wit
Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarte
U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Frid
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ